Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antineoplastic drugs, also known as anticancer drugs, anti-malignant drugs, refer to drugs for the treatment of malignant tumors.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Anticancer Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Anticancer Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Anticancer Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bayer AG
Pfizer Inc
AstraZeneca
Novartis AG
Amgen Inc
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
CELGENE CORPORATION
By Type:
Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
Hormonal Drugs
By End-User:
Lung Cancer
Breast Cancer
Leukemia
Colorectal Cancer
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anticancer Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Anticancer Drugs Market Size and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) from 2016 to 2027
-
1.3.2 China Anticancer Drugs Market Size and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) from 2016 to 2027
-
1.3.3 China Anticancer Drugs Market Size and Growth Rate of Hormonal Drugs from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Anticancer Drugs Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
1.4.2 China Anticancer Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
1.4.3 China Anticancer Drugs Market Size and Growth Rate of Leukemia from 2016 to 2027
-
1.4.4 China Anticancer Drugs Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Anticancer Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anticancer Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
-
3.4.2 Market Size and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
-
3.4.3 Market Size and Growth Rate of Hormonal Drugs
4 Segmentation of Anticancer Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anticancer Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Anticancer Drugs in Lung Cancer
-
4.4.2 Market Size and Growth Rate of Anticancer Drugs in Breast Cancer
-
4.4.3 Market Size and Growth Rate of Anticancer Drugs in Leukemia
-
4.4.4 Market Size and Growth Rate of Anticancer Drugs in Colorectal Cancer
5 Market Analysis by Regions
-
5.1 China Anticancer Drugs Production Analysis by Regions
-
5.2 China Anticancer Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Anticancer Drugs Landscape Analysis
-
6.1 North China Anticancer Drugs Landscape Analysis by Major Types
-
6.2 North China Anticancer Drugs Landscape Analysis by Major End-Users
7 Central China Anticancer Drugs Landscape Analysis
-
7.1 Central China Anticancer Drugs Landscape Analysis by Major Types
-
7.2 Central China Anticancer Drugs Landscape Analysis by Major End-Users
8 South China Anticancer Drugs Landscape Analysis
-
8.1 South China Anticancer Drugs Landscape Analysis by Major Types
-
8.2 South China Anticancer Drugs Landscape Analysis by Major End-Users
9 East China Anticancer Drugs Landscape Analysis
-
9.1 East China Anticancer Drugs Landscape Analysis by Major Types
-
9.2 East China Anticancer Drugs Landscape Analysis by Major End-Users
10 Northeast China Anticancer Drugs Landscape Analysis
-
10.1 Northeast China Anticancer Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Anticancer Drugs Landscape Analysis by Major End-Users
11 Southwest China Anticancer Drugs Landscape Analysis
-
11.1 Southwest China Anticancer Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Anticancer Drugs Landscape Analysis by Major End-Users
12 Northwest China Anticancer Drugs Landscape Analysis
-
12.1 Northwest China Anticancer Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Anticancer Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bayer AG
-
13.1.1 Bayer AG Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer Inc
-
13.2.1 Pfizer Inc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 AstraZeneca
-
13.3.1 AstraZeneca Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Novartis AG
-
13.4.1 Novartis AG Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Amgen Inc
-
13.5.1 Amgen Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Takeda Pharmaceutical Company Limited
-
13.6.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Eli Lilly and Company
-
13.7.1 Eli Lilly and Company Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 CELGENE CORPORATION
-
13.8.1 CELGENE CORPORATION Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Anticancer Drugs Market Size and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) from 2016 to 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) from 2016 to 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Hormonal Drugs from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Lung Cancer from 2016 to 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Breast Cancer from 2016 to 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Leukemia from 2016 to 2027
-
Figure China Anticancer Drugs Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Anticancer Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Anticancer Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Anticancer Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anticancer Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Anticancer Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Cytotoxic Drugs (Alkylating Agents, and Antimetabolites)
-
Figure Market Size and Growth Rate of Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors)
-
Figure Market Size and Growth Rate of Hormonal Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Anticancer Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Anticancer Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Lung Cancer
-
Figure Market Size and Growth Rate of Breast Cancer
-
Figure Market Size and Growth Rate of Leukemia
-
Figure Market Size and Growth Rate of Colorectal Cancer
-
Table China Anticancer Drugs Production by Regions
-
Table China Anticancer Drugs Production Share by Regions
-
Figure China Anticancer Drugs Production Share by Regions in 2016
-
Figure China Anticancer Drugs Production Share by Regions in 2021
-
Figure China Anticancer Drugs Production Share by Regions in 2027
-
Table China Anticancer Drugs Consumption by Regions
-
Table China Anticancer Drugs Consumption Share by Regions
-
Figure China Anticancer Drugs Consumption Share by Regions in 2016
-
Figure China Anticancer Drugs Consumption Share by Regions in 2021
-
Figure China Anticancer Drugs Consumption Share by Regions in 2027
-
Table North China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table North China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Anticancer Drugs Consumption Share by Types in 2016
-
Figure North China Anticancer Drugs Consumption Share by Types in 2021
-
Figure North China Anticancer Drugs Consumption Share by Types in 2027
-
Table North China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure North China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure North China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table Central China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table Central China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Anticancer Drugs Consumption Share by Types in 2016
-
Figure Central China Anticancer Drugs Consumption Share by Types in 2021
-
Figure Central China Anticancer Drugs Consumption Share by Types in 2027
-
Table Central China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure Central China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure Central China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table South China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table South China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Anticancer Drugs Consumption Share by Types in 2016
-
Figure South China Anticancer Drugs Consumption Share by Types in 2021
-
Figure South China Anticancer Drugs Consumption Share by Types in 2027
-
Table South China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure South China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure South China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table East China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table East China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Anticancer Drugs Consumption Share by Types in 2016
-
Figure East China Anticancer Drugs Consumption Share by Types in 2021
-
Figure East China Anticancer Drugs Consumption Share by Types in 2027
-
Table East China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure East China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure East China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Anticancer Drugs Consumption Share by Types in 2016
-
Figure Northeast China Anticancer Drugs Consumption Share by Types in 2021
-
Figure Northeast China Anticancer Drugs Consumption Share by Types in 2027
-
Table Northeast China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Anticancer Drugs Consumption Share by Types in 2016
-
Figure Southwest China Anticancer Drugs Consumption Share by Types in 2021
-
Figure Southwest China Anticancer Drugs Consumption Share by Types in 2027
-
Table Southwest China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Anticancer Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Anticancer Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Anticancer Drugs Consumption Share by Types in 2016
-
Figure Northwest China Anticancer Drugs Consumption Share by Types in 2021
-
Figure Northwest China Anticancer Drugs Consumption Share by Types in 2027
-
Table Northwest China Anticancer Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Anticancer Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Anticancer Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Anticancer Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Anticancer Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Amgen Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
-
Figure Sales and Growth Rate Analysis of Amgen Inc
-
Figure Revenue and Market Share Analysis of Amgen Inc
-
Table Product and Service Introduction of Amgen Inc
-
Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited
-
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited
-
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited
-
Table Product and Service Introduction of Takeda Pharmaceutical Company Limited
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of CELGENE CORPORATION
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CELGENE CORPORATION
-
Figure Sales and Growth Rate Analysis of CELGENE CORPORATION
-
Figure Revenue and Market Share Analysis of CELGENE CORPORATION
-
Table Product and Service Introduction of CELGENE CORPORATION
-
